C-proteinase inhibitors
US6462063B1 · kind B1 · utility
6Cited by
0References
28Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 4, 2000 |
| Grant date | Oct 8, 2002 |
| Priority date | — |
| Expiry date | Feb 4, 2020 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D405/06
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention relates to a novel class of N,N′-di substituted hydantoin hydroxamates capable of inhibiting C-proteinase, and to their use to regulate, modulate and/or inhibit abnormal collagen formation as a therapeutic approach towards the treatment of fibrotic disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.